|COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring.|
Engineering and medicine: Opportunities in type 1 diabetes
If you have a question about this talk, please contact Dr Jason Z JIANG.
The development of the artificial pancreas is underway with considerable stakeholders input and industry interest. Aimed to treat type 1 diabetes of all ages from early childhood to maturity, the artificial pancreas consists of a continuous glucose meter, control algorithm and an insulin pump. Significant life sciences opportunities exist to complement the clinical work and accelerate research progress and commercialisation of the artificial pancreas.
This talk is part of the CUED Control Group Seminars series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
Other listsMedieval Economic and Social History Seminars Martin Centre Research Seminar Series - 40th Annual Series of Lunchtime Lectures Visual rhetoric and modern South Asian history
Other talksProf Massimo Piepoli: TBC Peru, from coast to the Andes Moving Forward with Stem Cell Therapy Bayesian dynamic modelling of network flows The CRISPR-Cas bacterial adaptive immune systems What’s new (and what isn’t) in improving quality and safety in healthcare